Welcome!

Weblogic Authors: Yeshim Deniz, Elizabeth White, Michael Meiner, Michael Bushong, Avi Rosenthal

News Feed Item

Erasmus University Medical Center Rotterdam Chooses Oracle to Support Genomic Research and Advance Personalized Medicine

Healthcare Organization Accelerates Insights With Oracle Health Sciences Translational Research Center Running on Oracle Exadata Database Machine

REDWOOD SHORES, CA -- (Marketwired) -- 07/07/14 -- Oracle (NYSE: ORCL)

News Summary
As an institute at the forefront of patient-centered care and medical research, Netherlands-based Erasmus Medical Center Rotterdam (Erasmus MC) seeks to accelerate genomic research and advance personalized medicine. The academic medical center selected Oracle Health Sciences Translational Research Center running on Oracle Exadata Database Machine as the foundation for its next-generation genomics initiatives. The solution will help the medical center accelerate insight that will drive new treatments and improve patient outcomes.

News Facts

  • Erasmus MC, the largest university medical center in the Netherlands, selected Oracle Health Sciences Translational Research Center to support next-generation research initiatives to advance personalized medicine and improve patient outcomes.
  • Erasmus MC plans to use the solution, which enables researchers to simultaneously analyze clinical and omics data, to reveal new insights, such as the discovery and validation of new biomarkers, which are expected to lead to more effective, personalized treatment recommendations.
  • The inaugural project will focus on improving care and outcomes for patients with craniofacial malformations. The initiative will involve whole genome sequencing for > 1000 patients.
  • Subsequently, Erasmus MC expects to deploy the platform across the enterprise, integrating clinical, operational and financial data to accelerate diagnosis, improve care, and gain insight into cost-effectiveness of specific treatments.
  • Oracle Health Sciences Translational Research Center is a comprehensive platform that normalizes, aggregates, controls, and analyzes diverse clinical and molecular data to help researchers identify new predictive biomarkers and rapidly find subjects with similar clinical and omics characteristics to advance personalized medicine.
  • Erasmus MC selected Oracle Health Sciences Translational Research Center because the organization believes it is ideally suited to provide its clinicians with the ability to rapidly analyze genotypic and phenotypic data from multiple internal and external sources at scale, increasingly necessary as whole genome sequencing moves into the clinic.
  • Erasmus MC will run Oracle Health Sciences Translational Research Center on Oracle Exadata Database Machine, which will help ensure extreme performance on an enterprise-wide scale.

Supporting Quotes

  • "Oracle Health Sciences Translational Research Center -- and its ability to simultaneously query clinical and omics data -- will be vital to advancing our next-generational genomics research initiatives," said Jan A. Hazelzet, CMIO, Erasmus MC. "As we expand the deployment across our enterprise, the platform's centralized data warehouse will enable in-depth analysis of patient outcomes and cost of care from a single source of truth. We look forward to benefitting from Oracle's innovative, secure and scalable solution."
  • "Oracle is committed to helping health sciences organizations drive innovation with solutions such as Oracle Health Sciences Translational Research Center," said Jonathan Sheldon, PhD, Global Vice President, Oracle Health Sciences. "The solution, running on Oracle Exadata Database Machine will provide Erasmus MC with the ability to unlock critical insight in its quest to advance personalized medicine."

Supporting Resources

About Oracle
Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NYSE: ORCL), visit www.oracle.com.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info
Greg Lunsford
Oracle
+1.650.506.6523
Email Contact

Mary Tobin
O'Keeffe & Company
+1.503.658.7396
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

IoT & Smart Cities Stories
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence. Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busine...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
Whenever a new technology hits the high points of hype, everyone starts talking about it like it will solve all their business problems. Blockchain is one of those technologies. According to Gartner's latest report on the hype cycle of emerging technologies, blockchain has just passed the peak of their hype cycle curve. If you read the news articles about it, one would think it has taken over the technology world. No disruptive technology is without its challenges and potential impediments t...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of San...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...